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Abstract
Background: The rapid determination of pathogenic agent is very important to clinician for guiding their clinical
medication. However, current diagnostic methods are of limitation in many aspects, such as detecting range,
time-consuming, specificity and sensitivity. In this report, we apply our new-developing pathogen detection method
to clarify that Propionibacterium acnes is the causative agent of a two-year-old boy with juvenile myelomonocytic
leukemia presenting clinical symptoms including serious rash and hyperpyrexia while traditional clinical methods of
diagnosis fail to detect the pathogenic agent and multiple antimicrobial drugs are almost ineffective Propionibacterium
acnes is confirmed to be the infectious agent by quantitative real-time polymerase chain reaction.
Case presentation: After haploidentical hematopoietic stem cell transplantation, a two-year-old boy with juvenile
myelomonocytic leukemia presented to a pediatrist in a medical facility with hyperpyrexia and red skin rash which
later changed to black skin rash all over his body. Traditional diagnostic assays were unrevealing, and several routine
antimicrobial treatments were ineffective, including the vancomycin, meropenem, tobramycin, cefepime and rifampin.
In this case, pediatrist resorted to the next-generation sequencing technology for uncovering potential pathogens
so as to direct their use of specific drugs against pathogenic bacteria. Therefore, based on the BGISEQ100 (Ion
Proton System) which performed sequencing-by-synthesis, with electrochemical detection of synthesis, and each
such reaction coupled to its own sensor, which are in turn organized into a massively parallel sensor array on a
complementary metal-oxidesemiconductor chip, we detect and identify the potential pathogens. As a result, we
detected a significantly higher abundance of skin bacteria Propionibacterium acnes in patient’s blood than controls. It
had been reported that patients infected by Propionibacterium acnes almost always had history of immunodeficiency,
trauma or surgery. Considering this possible cause, antimicrobial treatment was adjusted to target this rare
opportunistic pathogen. Fever and black skin rashes were rapidly reduced after administrating specific drugs against
Propionibacterium acnes.
Conclusion: This case showed our new-developing pathogen detection method was a powerful tool in assisting
clinical diagnosis and treatment. And it should be paid more attention to Propionibacterium acnes infection in clinical
cases.
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Background
Propionibacterium acnes (P. acnes) is a skin commensal
bacterium. On rare occasions, it can cause serious post-
operative complications, such as infective endocarditis,
thrombophlebitis, and acute suppurative pericarditis, es-
pecially in immunodeficiency patients who are highly
susceptible to pathogenic microorganisms. And these
infections often run an acute course due to the weak or
late inflammatory response [1], but their clinical symp-
toms are usually atypical, making them very difficult to
diagnose. Till now, there have been various pathogen-
detecting methods applied in clinic, such as isolation and
culture, serological test, specific polymerase chain reaction
(PCR) and its derivatives and so on, but all these methods
are almost always based on the known sequences or com-
ponents and usually target one or several major known
pathogens, presenting serious limitations [2]. As the devel-
opment of sequencing technology with its cost continually
falling, next-generation sequencing (NGS) has become an
attractive tool for broad-based pathogen discovery. NGS
have strong potential to detect and identify almost var-
ieties of microorganisms, including known and unknown.
In 2008, Palacios G et al. identified a new virus from three
patients who received visceral-organ transplants from a
single donor by high-throughput sequencing, showing a
powerful tool for discovery of new pathogens [3]. In 2013,
a 14-year-old boy was enrolled for pathogen detection
by use of NGS because of the failure of traditional diag-
nostic assays, resulting ultimately in a favorable out-
come [4],which indicated that the pathogen detection
method based on NGS could be useful in clinical cases,
Recently, a semiconducting sequencing platform (BGI-
SEQ100) has been improved greatly, possessing some
remarkable technique features, such as fast (sequencing
within 2–3 h), flexible (flexible scaled chips for different
throughput needs) and high accuracy (99.97 %). Here,
we utilize this platform to develop a pathogen detection
method for discovering the potential pathogens of un-
known infection, successfully identifying an opportunis-
tic pathogen (P. acnes) that may be the major cause of
serious infection of a two-year-old boy. Our result
shows a reliable method for detecting potential patho-
gens of unknown infection in HSCT patients, indicating
its strong application values in clinic.
Case presentation
On January 5th, 2014, a 2-year-old boy with JMML was
presented to the pediatric hematology and oncology de-
partment for abnormal hemogram lasting for two
months. Then, he was admitted to the hospital and dis-
charged 8 days later after completing the Human
Leukocyte Antigens (HLA) matching (Fig. 1a). Subse-
quently, he continued with chemotherapy and outpatient
medications, including mercaptopurine, prednisone, and
13-cis-retinoid acid (isotretinoin).
On June 5th, 2014, the patient returned to the hospital
for preparation before HSCT. His vital signs were nor-
mal, and physical examination was unremarkable except
some discrete old rashes on skin (Fig. 2). The result of
hospital laboratory examinations was also normal. Since
June 10th, patient started to receive a myeloablative con-
ditioning regimen [busulfan (BU) 1.2 mg/kg iv. q6h for
4 days, cyclophosphamide (CTX) 50 mg/kg iv. qd for
4 days and anti-thymocyte globulin (ATG) 3.3 mg/kg iv.
qd for 3 days]. However, the patient suffered from fever
(up to 39.8 °C) with mild cough and running nose since
June 15th, indicating respiratory infection. Subsequently,
clinical examinations were performed to analyze the pos-
sible cause. The blood/marrow culture were negative.
The number of his peripheral white blood cells and neu-
trophils was 7500 and 2450 per cubic millimeter, re-
spectively. The C-reactive protein (CRP) was above
200 mg per liter (normal range, 0 to 5 mg per liter). The
procalcitonin (PCT) was 0.15 ng per milliliter (normal
range, 0 to 0.1 ng per milliliter). The G test which was
target for broad spectrum dectection of fungal infection
was 20.6 pg per milliliter (normal range, 0 to 20 pg per
milliliter). All these results from assays of serum liver-
enzyme, usea nitrogen, creatinine, electrolyte and patho-
gen specific antigen were within range of normal value.
However, the result of chest X-ray showed increased
lung-markings. Consequently, the patient was treated
with meropenenm (MEM) targeted for gram-negative
and other refractory bacteria, and vancomycin (VANC)
targeted for gram-positive cocci. Meanwhile, antifungal
agent caspofungin acetate (CAS) and antiviral agent
acyclovir (ACV) were also administered as prophylaxis
(Fig. 1b).
The patient underwent the cord blood transplantation
and HSCT (the donor was his mother) on June 20th and
21th, respectively. From June 15th to June 24th, patient’s
body temperature dropped to 38.5 °C from 40.5 °C, then
rose to 40.3 °C again (Fig. 1c). Meanwhile, CRP dropped
to 8.5 mg per liter (normal range, 0 to 5 mg per liter).
Although treatments had been performed regularly, his
symptoms of fever, chills and cough still didn’t lighten.
Physical examination showed some previous discrete
rashes and coarse lung sounds. CRP was 119.2 mg per
liter (normal range, 0 to 5 mg per liter). MEM and VANC
almost had no effect on the clinical symptoms. Then, his
primary care physician decided to switch drugs to linezo-
lid (LZD) against gram-positive cocci, tobramycin (TOB)
against gram-negative bacteria for a week, and voricona-
zole for fungal prophylaxis (Fig. 1b).
During this period, patient also experienced anemia
and thrombocytopenia occasionally. After transfusion of
washed red blood cells and platelets for skin bleeding,
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the number of his hemoglobin and platelets returned to
normal. During the next two weeks, he still presented
with fever, mild expectoration and some discrete old
rashes, suggesting the possibility of tuberculosis bacillus
infection. Considering the medication safety, the doctor
stopped using TOB and LZD, and changed to use the ri-
fampicin (RFP) and fusidic acid against gram-positive bac-
teria and tazocin against drug-resistance gram-negative
bacteria (Fig. 1b). On July 13th, lumber puncture was
performed to collect cerebrospinal fluid (CSF) for tubercle
bacillus detection, but no positive results were obtained
by culture and PCR based methods. After a week, the
computed tomography (CT) of chest showed pneumonia
in the posterior basal segment of the lower lobe of right
lung (Fig. 3c/d), and CRP became 0.2 mg per liter (normal
range, 0 to 5 mg per liter), but his body temperature still
fluctuated between 37.7 °C and 39 °C. Finally, we got the
informed consent of patient’s mother on behalf of the
Fig. 1 Clinical course (Panel a), antibiotic regimens (Panel b), body temperature and leukocyte count (Panel c) of the 2-year-old patient with hyperpyrexia
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patient for detecting potential pathogens based on NGS
technology (Fig. 1a).
Within 43 h after collecting patient’s blood, we fin-
ished the detection of pathogens, identifying 22,123 (out
of 2,602,891) sequence reads (0.8499 %) uniquely corre-
sponding to Propionibacterium acnes (P. acnes, G+) gen-
ome. P. acnes accounted for a very high proportion in
detectable microorganisms and possessed a high cover-
age of genome, which was also significantly higher than
control (Fig. 5). This result was re-confirmed by the
NGS detection and species specific real-time PCR
(RT-PCR). Based on the result, the primary care phys-
ician turned to adopt specific drugs for treatment of P.
acnes infection immediately, including VANC, cipro-
floxacin (CPFX) and amikacin (AMK) against gram-
positive bacteria, CAS and ACV for prophylaxis of fun-
gal and virus infections.
Over the next 5 days, the patient gradually recovered
with his body temperature returning to normal range
and his old rash fading (Fig. 2c/d). However, other com-
plications still persisted, such as the graft versus host
disease (GVHD).
Methods
The NGS-based pathogen detection of patient’s blood
sample was approved by his parents and primary care
physician. Blood samples were processed in a medical la-
boratory according to the Ion Torrent next-generation
sequencing assay manual (BGISEQ100). The general de-
tection process was: 1) 200 μl plasma was used to
Fig. 2 The situation of skin rashes on patient’s body in two time-points (pre- and post-treatment). The patient presented hyperpyrexia with black
rash all over his body in the first detection (Panels a, b). The patient’s body temperature returned to normal with the rash fading in the second
detection (Panels c, d)
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extract nucleic acid for cDNA libraries; 2) sequencing
was performed by BGISEQ100 after library was validated
by 2100 Bioanalyzer system (Agilent Technologies, Inc.)
and RT-PCR. Sequence reads were classified according
to their origin by a bioinformatics pipeline developed by
BGI (Fig. 4). The bioinformatics process mainly included
the following steps: 1) host reads were subtracted; 2)
remained reads were aligned to reference database, com-
posed of multiple public sequence resources of bacteria,
viruses and fungi. And the reference database was con-
structed according to the following steps:
1) downloaded all complete genome sequences of
Bacteria, Virus from NCBI ftp site ftp://ftp.ncbi.
nih.gov/genomes/;
2) removed the plasmid sequence and any other
non-human-related sequence;
3) kept only one best genome sequence representing
every species based on the assembly result;
4) built the alignment index of reference sequence for
classing sequence reads.
In order to validate the result of NGS-based detec-
tion,specific primers were designed to detect the P.
acnes in samples by RT-PCR. In order to accurately
compare the relative abundance difference of P.acnes
among different samples, human beta-actin was used as
the internal reference. The designed primers were listed
as:
KPA171202 of P.acnes (PA-F:5′-GCGTGAGTGACG
GTAATGGGTA-3′ and PA-R:5′-TTCCG ACGCGAT




Rapid identification of P. acnes sequences in blood
plasma
In detection of each sample, we selected a control sam-
ple from a non-infected patient in the same ward to do
the same detection.In all of the four samples, the RNA
of each sample was extracted to construct the cDNA li-
brary for sequencing. As the sequencing result, the num-
ber of reads from cDNA library of patient’s plasma was
2,602,891, and that of control was 4,294,544. As the re-
sult of pathogen detection, P. acnes was identified as the
most predominant pathogen taking up 0.85 % (22,123
out of 2,602,891) of total sequence reads, 19.98 % of
total bacterial reads and 65 % coverage of P. acnes gen-
ome in the first detection but reduced to 0.0048 % (350
out of 7,250,976 reads) of total sequence reads, 0.43 % of
bacterial reads and 1.5 % coverage of P. acnes genome in
the second detection after specific drug treatments,
Fig. 3 The results of chest X-ray, CT of patient. The chest X-ray images showed slightly increased lung-markings from Jun 17th to July 9th
(Panels a, b), and images of chest CT revealed pneumonia in the posterior basal segment oflower lobe of right lung on July 22nd (Panels c, d)
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approximate to the number of P. acnes reads in control
(Fig. 5 and Table 1).
Confirmatory testing for P. acnes
Identification of P. acnes in patient’s plasma was confirmed
by RT-PCR targeted the specific gene KPA171202.As the
RT-PCR result, it was no statistically significant (P = 0.56,
Student’s t-test) of the negative control in two detections,
but the patient was higher (P = 0.0056) than negative in
the first detection and it was significantly reduced
(P = 0.00094) in the second detection (Fig. 6), which
showed a high consistency with the NGS-based result.
Discussion
P. acnes is a typical gram positive, anaerobic bacterium,
which belongs to the normal skin microbiota, usually
colonize skin surface and closely link with skin acne.
However, its potential role in clinical infection is often
underestimated due to its low virulence [5]. Furthermore,
P. acnes is rarely diagnosed to be the major pathogen lead-
ing to serious infection not only for its pathogenicity but
also methology. In aspect of clinical pathogen detection,
the most common method is the culture-based method,
but it possesses very poor sensitivity and accuracy and
often needs to consume a large amount of time (>7d) to
grow microbe for analysis. Other traditional detection
methods are also becoming more and more of limitation
due to continual variation of microorganisms, emergence
of new pathogens and flaw of method itself such as low
accuracy, poor specificity and so on. Therefore, it is highly
necessary to develop or utilize new detection methods to
cope with these limitations. The NGS-based pathogen de-
tection is a new-developing method for scanning the mi-
crobial sequences in clinical samples, by which we can
easily identify potential pathogens for performing specific
antimicrobial treatment. In clinic, P. acnes is gradually
recognized as an important factor of human opportunistic
infection as the number of clinical case appears to be on
the rise [6–11]. However, atypical symptoms of P. acnes
infections often lead to the confusion with postoperative
complications, such as prosthetic joint infection, pace-
maker endocarditis, and implant-associated infections [6].
In this case, although his antibody of HIV was always
negative, with nutritional support therapy against malnu-
trition, it is highly possible that this patient is infected by
the opportunistic P. acnes resided in the skin dermis be-
cause of his defective immune system [12]. The significant
differences of read number and genomic coverage of P.
acnes between patient and control and pre- and post-
treatment strongly indicate the infection of P. acnes.
Fig. 4 The schematic overview of BGI analysis pipeline
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Before confirming infection of P. acnes, Pediatricians
had to choose various drugs targeting viruses, fungi, and
bacteria (G+ bacterium, G− bacterium, bacillus and coc-
cus) base on the principles of minimum damage to pa-
tients and universal prescription drug coverage. However,
P. acnes is able to form biofilm, which renders it resistant
to most antibiotics [13, 14], such as daptomycin and ri-
fampin [14, 15]. The recently published report suggests
that the combination of daptomycin and rifampin,
followed by levofloxacin and rifampin, might be a reason-
able treatment for P. acnes infection [15]. Subsequently,
the primary care doctor administrates drugs according to
the reported dosage regimen, attaining an effective treat-
ment. Additionally, biofilm formation is essential for re-
sistance of some bacteria to drug. P. acnes has been
shown to be able to form biofilm both in vitro and in vivo
[16], which also highlights the important influence of bio-
film in treatment of P. acnes infection [17].
Table 1 The basic situation of P. acnes in twice NGS-based detections
Item Reads number
of P. acnes
Proportion of P. acnes
reads in total reads
Coverage of P. acnes
genome
Depth of P. acnes
genome
First detection (case) 22,123 0.8499 % 65.00 % 1.9
First detection (control) 3,811 0.0887 % 17.00 % 1.2
Second detection (case) 350 0.0048 % 1.50 % 1.2
Second detection (control) 345 0.0048 % 1.40 % 1.3
Fig. 5 Diagnosis of P. acnes infection by the NGS-based method: mapping of P. acnes reads (Panel a) and sequences in blood of two detections (Panel b)
Ye et al. BMC Infectious Diseases  (2016) 16:5 Page 7 of 9
Conclusion
In summary, our NGS coupled with an efficient bioinfor-
matics pipeline successfully identified an opportunistic
pathogen responsible for an infection of unknown origin,
which eluded conventional assays in clinic, powerfully
assisting doctors in selecting the most targeted and ef-
fective treatment for patients. The present case study
also has important clinical implications, P. acnes infec-
tions may continue to increase in the patients with
immuno-compromise in the future, and an optimal anti-
microbial regimen needs to be defined.
Consent
Written informed consent was obtained from the pa-
tient’s parent for publication of this case report. A copy
of the written consent is available for review by the
Editor of this journal.
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